Viewing Study NCT02839135


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-02-03 @ 4:00 AM
Study NCT ID: NCT02839135
Status: COMPLETED
Last Update Posted: 2018-05-18
First Post: 2016-07-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-05-13
Start Date Type: ACTUAL
Primary Completion Date: 2016-08-01
Primary Completion Date Type: ACTUAL
Completion Date: 2016-08-10
Completion Date Type: ACTUAL
First Submit Date: 2016-07-18
First Submit QC Date: None
Study First Post Date: 2016-07-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-05-17
Last Update Post Date: 2018-05-18
Last Update Post Date Type: ACTUAL